Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Worldwide Offices
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Stakeholders in Clinical Trials Market Harness Internet of Medical Things (IoMT) to Explore New Frontiers in Vaccine Development: TMR

      This image opens in the lightbox

      News provided by

      Transparency Market Research

      11 Feb, 2021, 13:30 GMT

      Share this article

      Share this article


      - Growing regulatory push for adoption of telemedicine to help combat operational challenges in COVID-19 trials

      - Clinical trial management groups harness virtual trial tools to boost recruitment,  paving way to innovations

      ALBANY, N.Y., Feb. 11, 2021 /PRNewswire/ -- Clinical trials community, including industry and the academia, has been relentlessly conducting studies to mitigate and prevent outbreaks of infectious diseases. Ongoing trials around the world underpin hopes of new drugs and therapies. The recent one, COVID-19 pandemic, has brought forth several unique challenges for the trial managers, upending the whole trial processes.  Unprecedentedly, the COVID-19 has caused community-wide disruptions, pressing for urgent need for speeding up the current trials in various nations. In the backdrop of these trends, the clinical trials market is poised to witness new avenues over new few months. Unique set of challenges faced by trial managers include low recruitment of participants, uncertainties in data collection, and recurrent concern of patients' safety as well as healthcare staff.

      All in all, the researchers at TMR foresees a vast potential: by 2030, the clinical trials market is expected to surpass US$ 83.5 Bn. International trial management groups are likely to benefit from guidance from regulatory agencies such as the U.S. FDA and European Medicines Agency (EMA).

      Request for Analysis of COVID-19 Impact on Clinical Trials Market – https://www.transparencymarketresearch.com/covid19.php

      Key Findings in Clinical Trials Market

      • Guidelines by Regulatory Agencies to Set Up New Protocols for In-person visits

      Patients' safety has been one of the top concerns stakeholders in the clinical trials market have to grapple due to COVID-19 pandemic exposures. The US Food and Drug Administration (FDA) and the National Institute for Health Research (NIHR) had come with new norms in 2020 to ensure patient's safety, for instance. Thus, investigators and sponsors are adopting protocols that reduce in-person visits. In particular, patients are exhorted to go for virtual clinical trials. These protocols are likely to govern non-COVID-19 trials as well, notably those related to cardiovascular diseases and cancer.

      Request Brochure of Clinical Trials Market Report - https://www.transparencymarketresearch.com/brochure.php

      • Telemedicine Emerging as Popular Virtual Tools to Fill Gaps

      The COVID-19 pandemic has brought fresh avenues in clinical trials market. A case in point is telemedicine, the business proposition for which is fast building up. Regulatory thrust is expected to spur interest of clinical trials managers, trial sponsors, and researchers to clear the administrative hurdles in the use of telemedicine to expedite COVID-19 vaccine trials. Concerns to meet the urgent need for improving the quality of clinical trials are expected to be key underpinnings of the adoption of telehealth in future as well. Telehealth also shows potential in mitigating challenges related to site management and compliance norms for clinical trial managers.

      IoMT to Set Tone for Innovation in Clinical Trials Market

      Internet of Medical Things (IoMT) is emerging as a new frontier to bring various partners in clinical development programs on the same page. The IoMT ecosystem opens new promises to improve trial outcomes. Past epidemics have seen IoMT technologies put to mitigate infection spread. Concomitantly, advance in sensors and IoT frameworks will spur investments by clinical trials sponsors on IoMT. The growing use of digital biomarkers to monitor trial outcomes is a case in point. Thus, IoMT will act as a key lever as well as a robust accelerant in boosting the growth of the clinical trials market. The expanding point-of-care devices and wearables is also expanding the use cases of IoMT in medical ecosystem.

      Purchase the Clinical Trials Market Report - https://www.transparencymarketresearch.com/checkout.php

      Clinical Trials Market: Key Driving Factors and Promising Avenues

      • Prevalence of chronic diseases in developing and developed regions of the world has spurred the number of clinical trials
      • Rise in investment by biotech and pharmaceutical companies to support new avenue sin the clinical trials market.
      • The shift toward discovering precision medicine in oncology and autoimmune diseases is a key trend for vaccine developers and drug makers
      • Global coalition by governments and private stakeholders toward speeding up trials of COVID-19 vaccine is expanding the canvas for players in the clinical trials market.

      Clinical Trials Market: Key Players

      • IMS Health
      • Icon plc
      • Medpace Holdings, Inc.
      • WuXi AppTec
      • Charles River Laboratories, Inc.
      • PPD, Inc.
      • PRA Health Sciences, Inc.

      Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:

      Telemedicine Market: https://www.transparencymarketresearch.com/telemedicine-market.html

      Digital Biomarkers Market: https://www.transparencymarketresearch.com/digital-biomarkers-market.html

      About Us

      Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

      Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

      TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

      Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm

      Contact

      Mr. Rohit Bhisey
      Transparency Market Research
      State Tower,
      90 State Street,
      Suite 700,
      Albany NY - 12207
      United States
      USA - Canada Toll Free: 866-552-3453
      Email: sales@transparencymarketresearch.com 
      Press Release Source: https://www.transparencymarketresearch.com/pressrelease/clinical-trials-market.htm  
      Website: https://www.transparencymarketresearch.com/

      Logo: https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.